# Growth Hormone Signaling in Vivo in Humans

> **NCT00512473** · NA · COMPLETED · sponsor: **University of Aarhus** · enrollment: 8 (actual)

## Conditions studied

- Intracellular Signaling Peptides and Proteins

## Interventions

- **DRUG:** Saline infusion
- **DRUG:** Human Growth Hormone
- **DRUG:** Pegvisomant

## Key facts

- **NCT ID:** NCT00512473
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2007-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00512473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00512473, "Growth Hormone Signaling in Vivo in Humans". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00512473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*